L
LeonaBio Inc. D
D
LONA
9.09000
USD
-0.64
(-6.53%)
Market Closed
Volume
810
EPS
0
Div Yield
-
P/E
-0
Market Cap
85,387,042
Title: LeonaBio Inc.
Sector: Healthcare
Industry: Biotechnology
LeonaBio Inc is a clinical-stage biopharmaceutical company focused on the development of novel therapeutics for high unmet medical needs. Its key drug candidates, lasofoxifene and ATH-1105, are novel, small-molecule therapies with the potential to address treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS). LeonaBio is also exploring the use of other drug candidates that enhance the neurotrophic HGF system, including ATH-1020, to improve neuronal health and function in multiple neurological diseases. In addition, it is also focused on designing and testing new early compounds directed towards novel targets for a variety of clinical applications. The company operates as a singleoperating segment, developing and commercializing therapeutics.